Skanska signs new tenant lease at 99M in Washington, D.C., USA

This post was originally published on this site

Thu, Jul 11, 2019 14:00 CET

Skanska has signed a lease for 11 years with CommonGrounds Workplace for approximately 4,100 square meters at its 99M office development in Washington, D.C., USA. The flexible workplace provider will take occupancy in spring 2020. With this transaction, the office portion of the development project is now 76 percent leased.

99M is an 11-story, 22,000-square-meter, LEED® Gold, Class-A office development in Washington, D.C.’s Capitol Riverfront. Skanska began construction in July 2015 and completed construction in the second quarter of 2018.

Skanska is one of the leading development and construction companies in USA, specialized in building construction, civil infrastructure and developing commercial properties in select U.S. markets. Skanska USA had sales of SEK 67 billion in 2018 and had about 9,000 employees in its operations.

For further information please contact:

Jacob Birkeland, Head of Media Relations, Skanska AB tel +46 (0)104491957

Beth Miller, Vice President, Communications, Skanska USA tel +1 917 438 4523

Direct line for media, tel +46 (0)10 448 88 99

This and previous releases can also be found at

Skanska is a world leader in construction and project development on select markets in the Nordic region, Europe and USA. Driven by the Group’s values, Skanska wants to contribute to a better society. Skanska provides innovative, sustainable solutions for both simple and complex assignments. Skanska has about 38,000 employees, and 2018 revenue totaled SEK 170 billion.

Recommended For You


About the Author: Sidney Martin

Sidney Marin Is a researcher and law student at York University (TORONTO). He has worked as the Director of the Graduate Lawyering Program. He worked for American law firms in Moscow, Russia for three years. Hegraduated from Columbia Law School, Columbia School of International and Public Affairs and Harvard College. He research interest is in human rights and health law, with a particular focus on the law and policy of vaccination.